Clinical trials
Phase 3 trials in Denmark
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,133 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 26 |
| 2002 | 35 |
| 2003 | 48 |
| 2004 | 40 |
| 2005 | 64 |
| 2006 | 89 |
| 2007 | 75 |
| 2008 | 90 |
| 2009 | 87 |
| 2010 | 69 |
| 2011 | 88 |
| 2012 | 94 |
| 2013 | 100 |
| 2014 | 84 |
| 2015 | 93 |
| 2016 | 73 |
| 2017 | 86 |
| 2018 | 91 |
| 2019 | 100 |
| 2020 | 108 |
| 2021 | 118 |
| 2022 | 74 |
| 2023 | 79 |
| 2024 | 92 |
| 2025 | 108 |
| 2026 | 66 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,345 |
| Active, not recruiting | 239 |
| Recruiting | 232 |
| Terminated | 224 |
| Unknown status | 57 |
| Enrolling by invitation | 13 |
| Withdrawn | 11 |
| Not yet recruiting | 11 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 119 |
| Novartis Pharmaceuticals | 108 |
| AstraZeneca | 102 |
| Sanofi | 91 |
| Novo Nordisk A/S | 83 |
| Boehringer Ingelheim | 69 |
| Pfizer | 65 |
| Eli Lilly and Company | 57 |
| Bristol-Myers Squibb | 55 |
| GlaxoSmithKline | 54 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 82 |
| Pulmonary Disease, Chronic Obstructive | 59 |
| Breast Neoplasms | 50 |
| Diabetes Mellitus | 49 |
| Neoplasms | 48 |
| Multiple Myeloma | 46 |
| Carcinoma, Non-Small-Cell Lung | 42 |
| Prostatic Neoplasms | 41 |
| Crohn Disease | 38 |
| Obesity | 37 |
Trials
Showing 26 to 50 of 2,133. Each trial links to its page on Pharma Observatory.
2,033 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.